CW January 2006
Volume 15Issue Number 1 January 2006 ISSN 10593802 Point-of Care Test for Detecting Recurrent Bladder CancerBladder tumor marker NMP22 assay in voided urine is more effective in detecting recurrent disease than conventional lab tests.
Go to Previous Page Go to Next Page Source & Additional Reading H. Barton Grossman, a professor in M. D. Anderson?s Department of Urology and the study?s principal investigator. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW January 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |
